share_log

CVS Health | 13F-HR: Information required of institutional investment managers pursuant to Section 13(f)

CVS Health | 13F-HR: Information required of institutional investment managers pursuant to Section 13(f)

西維斯健康 | 13F-HR:投資機構季度報告
美股SEC公告 ·  11/09 05:44

牛牛AI助理已提取核心訊息

CVS Health Corp has submitted its Form 13F filing to the Securities and Exchange Commission (SEC) for the quarter ended September 30, 2024. The report, signed by Investment Manager Michael Motolo on November 8, 2024, in Woonsocket, RI, indicates that the company has a total of 5 holdings with a combined value of $230,201,649. The filing, which is a standard requirement for institutional investment managers, provides a snapshot of the company's holdings and is used to inform the SEC and the public of the investment manager's holdings. CVS Health Corp has confirmed that all information in the report is true, correct, and complete, and that the report includes all holdings required to be disclosed.
CVS Health Corp has submitted its Form 13F filing to the Securities and Exchange Commission (SEC) for the quarter ended September 30, 2024. The report, signed by Investment Manager Michael Motolo on November 8, 2024, in Woonsocket, RI, indicates that the company has a total of 5 holdings with a combined value of $230,201,649. The filing, which is a standard requirement for institutional investment managers, provides a snapshot of the company's holdings and is used to inform the SEC and the public of the investment manager's holdings. CVS Health Corp has confirmed that all information in the report is true, correct, and complete, and that the report includes all holdings required to be disclosed.
CVS Health Corp已向證券交易委員會(SEC)提交了截至2024年9月30日的第13f表格。該報告由投資經理Michael Motolo於2024年11月8日在RI Woonsocket簽署,顯示該公司共有5個持股,總價值爲230,201,649美元。這份文件是機構投資經理的標準要求,提供了公司持股的快照,並用於告知SEC和公衆投資經理的持股情況。CVS Health Corp已確認報告中的所有信息是真實、正確和完整的,並且報告包括了需要披露的所有持股。
CVS Health Corp已向證券交易委員會(SEC)提交了截至2024年9月30日的第13f表格。該報告由投資經理Michael Motolo於2024年11月8日在RI Woonsocket簽署,顯示該公司共有5個持股,總價值爲230,201,649美元。這份文件是機構投資經理的標準要求,提供了公司持股的快照,並用於告知SEC和公衆投資經理的持股情況。CVS Health Corp已確認報告中的所有信息是真實、正確和完整的,並且報告包括了需要披露的所有持股。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。